Strategic partnerships Preventx is the largest provider of remote sexual health testing in the UK and already partners with the NHS and local authorities. There is a clear sales angle to expand partnerships with additional public health bodies, healthcare providers, and pharmacy chains beyond Lloyds Pharmacy to broaden testing access and service integration.

Expansion opportunities Recent moves indicate geographic and market expansion, including US lab development and office expansion. This suggests openings to pursue international B2B collaborations, laboratory services, and remote testing platforms for new regional health systems, clinics, and insurers.

Lab and diagnostics The launch of an in-house or dedicated STI testing lab enhances diagnostic capabilities. This can be leveraged to upsell comprehensive testing panels, faster turnaround, white-label services for partners, and enterprise-level diagnostic solutions for health networks.

Digital platform value A scalable digital platform supporting self-sampling and telehealth services aligns with payer and provider needs for cost-effective remote care. Sales can focus on licensing, integration with existing EHR/PHR systems, and expanded online prevention and treatment offerings for public health programs.

Public sector foothold Active involvement with NHS and SH.UK / SH.London programs demonstrates credibility with government-backed healthcare initiatives. Opportunities exist to extend service lines, secure long-term contracts, and win additional tenders for remote testing, contraception, and treatment services in multiple regions.